Cargando…
Suppression of Expression of Heat Shock Protein 70 by Gefitinib and Its Contribution to Pulmonary Fibrosis
Drug-induced interstitial lung disease (ILD), particularly pulmonary fibrosis, is of serious clinical concern. Gefitinib, a tyrosine kinase inhibitor of the epidermal growth factor receptor (EGFR), is beneficial as a drug for treating non-small cell lung cancer; however, this drug induces ILD and th...
Autores principales: | Namba, Takushi, Tanaka, Ken-Ichiro, Hoshino, Tatsuya, Azuma, Arata, Mizushima, Tohru |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3212557/ https://www.ncbi.nlm.nih.gov/pubmed/22096546 http://dx.doi.org/10.1371/journal.pone.0027296 |
Ejemplares similares
-
Therapeutic effects of eperisone on pulmonary fibrosis via preferential suppression of fibroblast activity
por: Tanaka, Ken-ichiro, et al.
Publicado: (2022) -
Geranylgeranylacetone attenuates hepatic fibrosis by increasing the expression of heat shock protein 70
por: HE, WEI, et al.
Publicado: (2015) -
Heat shock protein 70 inhibitors suppress androgen receptor expression in LNCaP95 prostate cancer cells
por: Kita, Kazuaki, et al.
Publicado: (2017) -
Idebenone has preventative and therapeutic effects on pulmonary fibrosis via preferential suppression of fibroblast activity
por: Sugizaki, Toshifumi, et al.
Publicado: (2019) -
Heat shock protein 70 and anti–heat shock protein 70 antibodies in nasal secretions of patients with chronic rhinosinusitis
por: Tsybikov, Namjil N., et al.
Publicado: (2016)